BF, Biochemical failure; BT, Brachytherapy; C3D-RT, Conformal three-dimensional radiation therapy; CBCT, Cone-beam computed tomography; CCa, Cervix cancer; Dmax, Maximum dose; Dmean, Mean dose; Dmin, Minimum dose; Dx, Dose (in Gy) receiving x% of a volume or more; EBRT, External beam radiation therapy; EQD2, Equivalent dose in 2-Gy fractions; ESKD, End-stage kidney disease; FU, Follow-up; HPV, Human papillomavirus; IBT, Intracavitary brachytherapy; IMRT, Intensity-modulated radiation therapy; KT, Kidney transplant; Kidney allograft; LRDRT, Living related donor renal transplantation; MMF, Mycophenolate mofetil; NED, No evidence of disease; OAR, Organs at risk; OS, Overall survival; PCa, Prostate cancer; PDN, Prednisone; PP, Post-prostatectomy; PSA, Prostate-specific antigen; PTV, Planning target volume; Pelvic radiotherapy; Prostate cancer; RR, Risk ratio; RT, Radiation therapy; Renal transplant; SCCVa, Squamous cell carcinoma of the vagina; SIR, Standardized Incidence Ratio; TBI, Total body irradiation; VCa, Vaginal cancer; VMAT, Volumetric Modulated Arc Therapy; Vaginal cancer; Vx, Volume (in percentage) receiving x dose or more (in Gy); fr, Fractions; mo, Months